Fiona C Brown

9PUBLICATIONS
64CO-AUTHORS
Gene and molecular therapyEvolutionary psychological studiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2024
Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia.

Fiona C Brown, Xin Wang, Richard Birkinshaw

|Mar 30, 2023
Is BCL-xL the Achilles' heel of AEL and AMKL?

Fiona C Brown, Andrew H Wei

|Dec 15, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells.

Charis E Teh, Hongke Peng, Meng-Xiao Luo

|Oct 11, 2022
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Donia M Moujalled, Fiona C Brown, Chong Chyn Chua

|Dec 04, 2021
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death.

Sylvain Garciaz, Andrew A Guirguis, Sebastian Müller

|Apr 07, 2021
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Rachel Thijssen, Sarah T Diepstraten, Donia Moujalled

Pageof 2

Frequent Collaborators

6 joint publications

Andrew H Wei

5 joint publications

David C S Huang

4 joint publications

Andrew W Roberts

3 joint publications

Chong Chyn Chua